Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Dr. Helen E. Heslop, MD, DSc in 2013
The most common conditions of Medicare patients that Dr. Helen E. Heslop, MD, DSc treated during 2013 were hypertension.
75 | |
(No ratings)
Dr. Helen E. Heslop, MD, DSc is a medical oncologist in Houston, TX specializing in medical oncology, pediatric hematology/oncology and adult hematology. She graduated from University of Otago School of Medical Sciences. Dr. Helen E. Heslop, MD, DSc is affiliated with Baylor College of Medicine, Texas Children's, St. Luke's Health, Houston Methodist and Baylor St. Luke's Medical Center - Houston, TX.
1102 Bates Avenue
Houston, TX 77030
6551 Bertner Avenue Floor 15, Walter Tower
Houston, TX 77030
6565 Fannin Street Suite 800
Houston, TX 77030
6701 Fannin Street
Houston, TX 77030
Room: Txfc-164006
Houston, TX 77030
The most common conditions of Medicare patients that Dr. Helen E. Heslop, MD, DSc treated during 2013 were hypertension.
Hypertension | 75 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The most common conditions of Medicare patients that Dr. Helen E. Heslop, MD, DSc treated during 2014 were hypertension.
Hypertension | 75 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Dr. Helen E. Heslop, MD, DSc treated as a medical oncologist in Houston, TX during 2016 were hospital care and inpatient care.
Volume of procedures performed by Dr. Helen E. Heslop, MD, DSc for Medicare patients.
hospital care | 62 |
---|---|
inpatient care | 62 |
Information about Medicare patients treated by Dr. Helen E. Heslop, MD, DSc.
Male | 11 |
---|---|
Female | 12 |
The most common conditions of Medicare patients that Dr. Helen E. Heslop, MD, DSc treated during 2016 were hypertension, chronic kidney disease and high cholesterol.
Hypertension | 74 |
---|---|
High Cholesterol | 57 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 61 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Dr. Helen E. Heslop, MD, DSc treated as a medical oncologist in Houston, TX during 2017 were hospital care and inpatient care.
Volume of procedures performed by Dr. Helen E. Heslop, MD, DSc for Medicare patients.
hospital care | 56 |
---|---|
inpatient care | 56 |
The most common conditions of Medicare patients that Dr. Helen E. Heslop, MD, DSc treated during 2017 were hypertension.
Hypertension | 71 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Information about Medicare patients treated by Dr. Helen E. Heslop, MD, DSc.
Male | 12 |
---|---|
Female | 13 |
The most common conditions of Medicare patients that Dr. Helen E. Heslop, MD, DSc treated during 2020 were hypertension, high cholesterol and chronic kidney disease.
Hypertension | 75 |
---|---|
High Cholesterol | 72 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 68 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Volume of procedures performed by Dr. Helen E. Heslop, MD, DSc for Medicare patients.
The highest averages for the top procedures that Dr. Helen E. Heslop, MD, DSc treated as a medical oncologist in Houston, TX were hospital care and inpatient care.
hospital care | 59 |
---|---|
inpatient care | 59 |
Information about Medicare patients treated by Dr. Helen E. Heslop, MD, DSc.
Female | 2 |
---|---|
Male | 2 |
The highest averages of the most common conditions of Medicare patients that Dr. Helen E. Heslop, MD, DSc treated were hypertension, chronic kidney disease and high cholesterol.
Hypertension | 37 |
---|---|
High Cholesterol | 12 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 12 |
Asthma | 0 |
Osteoporosis | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Atrial Fibrillation | 0 |
Cancer | 0 |
Dementia | 0 |
Dr. Helen E. Heslop, MD, DSc graduated from University of Otago School of Medical Sciences. She is certified by the the Royal College of Pathologists of Australasia (FRCPA) and has a state license in Texas.
Medical School: University of Otago School of Medical Sciences
Board Certification: the Royal College of Pathologists of Australasia (FRCPA)
Licensed In: Texas
Dr. Helen E. Heslop, MD, DSc is associated with these hospitals and organizations:
Dr. Helen E. Heslop, MD, DSc does not have any reviews yet, be the first to leave a review of Dr. Helen E. Heslop, MD, DSc here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Helen E. Heslop, MD, DSc. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Gilead Sciences, Inc. |
$39,913
$39,913 |
|||||
---|---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation |
$24,103
KYMRIAH $23,970 |
KESIMPTA $21 |
$111 |
|||
GlaxoSmithKline, LLC. |
$4,875
$4,875 |
|||||
Takeda Pharmaceuticals U.S.A., Inc. |
$2,500
$2,500 |
|||||
National Marrow Donor Program |
$746
$746 |
|||||
Other |
$1,057
Yescarta $134 |
IDHIFA $133 |
Revlimid $97 |
NOXAFIL $49 |
JCAR017 $22 |
Other $622 |
Consulting Fee | $66,055 |
---|---|
Travel and Lodging | $5,346 |
Food and Beverage | $1,773 |
Education | $20 |
Dr. Helen Heslop is a specialist in adult hematology, medical oncology, and pediatric hematology/oncology in Houston, TX. Her clinical interests include leukemia, bone marrow aspiration, and bone marrow transplant. Dr. Heslop is affiliated with Texas Children's, Houston Methodist, and St. Luke's Health. She is a graduate of the University of Otago School of Medical Sciences. She has received professional recognition including the following: President, Foundation for Accreditation Cell Therapy; President, American Society of Blood and Marrow Transplantation; and President, American Society of Gene and Cell Therapy. She has an open panel in Houston, TX according to St. Luke's Health.